Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2024 年第 4 季持倉
持倉截至 2024/12/31，2025/2/13 申報。只含多頭部位，變化是跟 2024 年第 3 季比股數。
- 持股檔數
- 75
- 較 2024 年第 3 季 −2
- 總值
- $6.40 億
- 較 2024 年第 3 季 −$441.9 萬 (−0.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 1,161,237 | $4,552 萬 | 7.1% | +17,216+1.5% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 931,728 | $4,221 萬 | 6.6% | +267,530+40.3% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 425,000 | $3,259 萬 | 5.1% | +25,000+6.3% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,100,000 | $3,164 萬 | 4.9% | +100,000+10.0% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $3,086 萬 | 4.8% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 660,000 | $3,065 萬 | 4.8% | +10,000+1.5% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 82,500 | $2,546 萬 | 4.0% | −17,500−17.5% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 460,000 | $2,352 萬 | 3.7% | +60,000+15.0% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 285,000 | $2,231 萬 | 3.5% | −52,500−15.6% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 824,328 | $1,919 萬 | 3.0% | +325,908+65.4% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,500,000 | $1,856 萬 | 2.9% | +100,000+7.1% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,095,924 | $1,836 萬 | 2.9% | +130,312+13.5% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 425,000 | $1,797 萬 | 2.8% | −10,000−2.3% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 940,083 | $1,771 萬 | 2.8% | +79,684+9.3% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 389,241 | $1,637 萬 | 2.6% | +227,500+140.7% | 加碼 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $1,619 萬 | 2.5% | – | – | – |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $1,461 萬 | 2.3% | – | – | – |
| ESTAEstablishment Labs Holdings Inc. | COM | 279,445 | $1,287 萬 | 2.0% | −11,002−3.8% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 630,000 | $1,208 萬 | 1.9% | +405,000+180.0% | 加碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $1,187 萬 | 1.9% | – | – | – |
| INZYInozyme Pharma, Inc. | COM | 3,972,318 | $1,100 萬 | 1.7% | +1,150,000+40.7% | 加碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 425,000 | $1,092 萬 | 1.7% | −47,390−10.0% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 4,500,000 | $1,058 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 2,250,000 | $796.5 萬 | 1.2% | +750,000+50.0% | 加碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,575,000 | $771.8 萬 | 1.2% | −125,000−7.4% | 減碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 2,825,000 | $748.6 萬 | 1.2% | +2,825,000 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 368,698 | $714.9 萬 | 1.1% | +18,862+5.4% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 75,000 | $634.6 萬 | 1.0% | −5,000−6.3% | 減碼 | 歷史 |
| ERASErasca, Inc. | COM | 2,499,431 | $627.4 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 130,000 | $584.4 萬 | 0.9% | +105,000+420.0% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $574.4 萬 | 0.9% | – | – | – |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 300,000 | $564.0 萬 | 0.9% | −25,000−7.7% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 200,000 | $548.8 萬 | 0.9% | −100,000−33.3% | 減碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 130,000 | $501.8 萬 | 0.8% | +130,000 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 350,000 | $430.9 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 1,300,000 | $414.7 萬 | 0.6% | +800,000+160.0% | 加碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 550,765 | $409.2 萬 | 0.6% | +505,765+1,123.9% | 加碼 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $356.3 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 200,000 | $348.4 萬 | 0.5% | +200,000 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 50,000 | $345.2 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 237,935 | $333.1 萬 | 0.5% | +24,961+11.7% | 加碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 850,512 | $321.5 萬 | 0.5% | +550,000+183.0% | 加碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $321.3 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 159,614 | $306.0 萬 | 0.5% | −365,386−69.6% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 70,742 | $292.5 萬 | 0.5% | −4,258−5.7% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 100,000 | $286.8 萬 | 0.4% | +100,000 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 58,331 | $269.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $262.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $253.8 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 100,000 | $247.7 萬 | 0.4% | −125,000−55.6% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 800,000 | $212.0 萬 | 0.3% | +200,000+33.3% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 25,000 | $204.7 萬 | 0.3% | −25,000−50.0% | 減碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 800,000 | $199.2 萬 | 0.3% | +150,000+23.1% | 加碼 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,302,598 | $177.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 300,000 | $167.4 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 40,000 | $160.9 萬 | 0.3% | +40,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 50,000 | $159.6 萬 | 0.2% | +50,000 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,000,000 | $158.0 萬 | 0.2% | +1,000,000 | 新進 | 歷史 |
| NARIInari Medical, Inc. | Stock | 25,000 | $127.6 萬 | 0.2% | −35,000−58.3% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 410,586 | $126.0 萬 | 0.2% | −289,414−41.3% | 減碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 144,159 | $124.0 萬 | 0.2% | +144,159 | 新進 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 559,163 | $119.7 萬 | 0.2% | +559,163 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 1,015,340 | $106.6 萬 | 0.2% | −305,813−23.1% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 142,316 | $95.6 萬 | 0.1% | −108,862−43.3% | 減碼依 1 比 10 拆股換算 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 500,000 | $90.0 萬 | 0.1% | −1,000,000−66.7% | 減碼 | 歷史 |
| RADXRadiopharm Theranostics Ltd | SPONSORED ADS | 156,171 | $68.4 萬 | 0.1% | +156,171 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $55.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 9,992 | $25.2 萬 | <0.1% | −115,008−92.0% | 減碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 213,235 | $22.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 100,000 | $13.1 萬 | <0.1% | −73,351−42.3% | 減碼 | 歷史 |
| OMEROmeros Corp | COM | 9,958 | $9.84 萬 | <0.1% | +9,958 | 新進 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $9.56 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $4.71 萬 | <0.1% | 00.0% | 不變 | – |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 150,000 | $3.45 萬 | <0.1% | +150,000 | 新進 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $2,573 | <0.1% | 00.0% | 不變 | – |
選擇權（10 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $6,755 萬 | – |
| MESOMesoblast Ltd | ADR | $1,660 萬 | – |
| AMGNAmgen Inc | Stock | – | $781.9 萬 |
| NMRANeumora Therapeutics, Inc. | COM | – | $503.5 萬 |
| FLNAFilana Therapeutics, Inc. | COM | $410.5 萬 | – |
| GALTGalectin Therapeutics Inc | COM NEW | $321.5 萬 | – |
| IBRXImmunityBio, Inc. | COM | $64.0 萬 | – |
| BMEABiomea Fusion, Inc. | COM | $58.2 萬 | – |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | $35.4 萬 | – |
| SLNOSoleno Therapeutics Inc | COM | – | $8,990 |
2024 年第 3 季之後清倉（16 檔）
2024 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 3 季股數 | 2024 年第 3 季市值 | 2024 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KURAKura Oncology, Inc. | COM | 687,785 | $1,344 萬 | 2.1% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 725,106 | $798.3 萬 | 1.2% | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 35,000 | $785.8 萬 | 1.2% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 600,000 | $500.4 萬 | 0.8% | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 147,500 | $472.6 萬 | 0.7% | 歷史 |
| IMTXImmatics N.V. | SHS | 250,000 | $285.3 萬 | 0.4% | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 201,587 | $232.6 萬 | 0.4% | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 400,000 | $119.6 萬 | 0.2% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 15,000 | $105.4 萬 | 0.2% | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 250,000 | $63.8 萬 | 0.1% | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 119,900 | $58.6 萬 | 0.1% | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 51,727 | $30.3 萬 | <0.1% | 歷史 |
| MTVAMetaVia Inc. | COM | 89,222 | $28.3 萬 | <0.1% | 歷史 |
| GNLXGENELUX Corp | COM | 100,000 | $23.7 萬 | <0.1% | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 47,019 | $9.69 萬 | <0.1% | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 30,643 | $3.83 萬 | <0.1% | 歷史 |